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Although protein kinase A (PKA) activation is known to increase ciliary beat frequency in humans
the molecular mechanisms involved are unknown. We demonstrate that PKA is associated with
ciliary axonemes where it specifically phosphorylates a 23-kDa protein. Because PKA is often
localized to subcellular compartments in proximity to its substrate(s) via interactions with A-
kinase–anchoring proteins (AKAPs), we investigated whether an AKAP was also associated with
ciliary axonemes. This study has identified a novel 28 kDa AKAP (AKAP28)that is highly enriched
in airway axonemes. The mRNA for AKAP28 is up-regulated as primary airway cells differentiate
and is specifically expressed in tissues containing cilia and/or flagella. Additionally, both Western
blot and immunostaining data show that AKAP28 is enriched in airway cilia. These data dem-
onstrate that we have identified the first human axonemal AKAP, a protein that likely plays a role
in the signaling necessary for efficient modulation of ciliary beat frequency.
INTRODUCTION
Mucociliary clearance is an innate host defense mechanism
dependent on the coordinated beating of cilia lining the
conducting airways. Ciliary beat is achieved by coupling the
hydrolysis of ATP by dynein, the molecular motor of the
axoneme, to microtubule sliding. To achieve the precise
waveform and beat frequency necessary for efficient clear-
ance, a cilium requires the cooperative action of the 200
proteins that compose this organelle. A number of pharma-
cological studies have demonstrated that ciliary beat fre-
quency (CBF) is a highly regulated process (reviewed in
Satir and Sleigh, 1990; Wanner et al., 1996); however, very
little is known about the molecular events underlying these
regulatory mechanisms.
The influence of cAMP on ciliary motility has been stud-
ied in a variety of organisms. Studies of classical nonmam-
malian systems such as Paramecium, Tetrahymena, and Myti-
lus gill cilia show a strong correlation between increased
cAMP levels, subsequent activation of protein kinase A
(PKA), and increased axonemal motility (Stommel and Ste-
phens, 1985; Hamasaki et al., 1989; Christensen et al., 2001).
In mammalian airway tissues, a significant increase in CBF
results when intracellular cAMP levels are artificially raised
in ciliated cells (Tamaoki et al., 1989; Di Benedetto et al., 1991;
Wyatt et al., 1998). This increase is blocked by the addition of
kinase inhibitors, suggesting a role for both cAMP and PKA
in the modulation of CBF.
In human tissue, Morse et al. (2001) recently demonstrated
that a sustained receptor-mediated increase in CBF is depen-
dent on the production of cAMP. In these studies, applica-
tion of adenosine and its nonmetabolizable analog 5(N-
ethylcarboxamido)-adenosine (NECA) to nasal explants
generated a concentration-dependent, sustained increase in
CBF. Application of an adenylyl cyclase inhibitor greatly
diminished the NECA effect. By using additional pharma-
cological agents, the effects of adenosine and NECA were
shown to be mediated through the A2B receptor, which
couples to adenylate cyclase through Gs. Similar results
were obtained in hamster oviduct where Morales et al. (2000)
also demonstrated that adenosine stimulated CBF in an ad-
enylyl cyclase-dependent manner.
These pharmacological data suggest a role for PKA in the
regulation of CBF; however, little is known about the mo-
lecular events underlying this phenomenon. We are inter-
ested in determining whether the compartmentalization of
signaling molecules plays a key role in the efficient modu-
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lation of human CBF. Specifically, we want to determine
whether PKA is anchored in human ciliary axonemes in
proximity to a substrate whose phosphorylation state mod-
ulates CBF.
A diverse family of functionally related proteins called
A-kinase anchoring proteins (AKAPs) targets PKA to dis-
crete locations within a cell (reviewed in Colledge and Scott,
1999). AKAPs bind to the regulatory subunit dimer of the
PKA holoenzyme. Most characterized AKAPs bind to type II
(RII) regulatory subunits; however, a few AKAPs are known
to bind type I (RI) subunits or to bind either subtype of
regulatory subunit. In most instances, this interaction is
mediated via an amphipathic helix at the surface of the
AKAP. Each AKAP also contains unique subcellular-target-
ing information. Through a protein–protein and/or protein–
lipid interaction, AKAP and PKA are specifically localized to
a particular organelle or membrane within the cell.
In our study, we have found that a pool of PKA is com-
partmentalized in human ciliary axonemes. We have also
determined the molecular identity of AKAP28, a novel
AKAP that is highly enriched in airway cilia. We propose
that AKAP28 anchors the PKA holoenzyme in the axoneme
in proximity to its substrate(s).
MATERIALS AND METHODS
Cell Culture
Human bronchial epithelial (HBE) cells from normal subjects or
cystic fibrosis patients were obtained from excess surgical tissue
under protocols approved by the University of North Carolina
Institutional Review Board. Passage 1 HBE cells were grown at an
air-liquid interface on semipermeable supports as described previ-
ously (Gray et al., 1996; Bernacki et al., 1999; Zhang et al., 2002). HeLa
cells were grown in DMEM supplemented with 10% fetal bovine
serum.
Isolation and Phosphorylation of Axonemes
Axonemes were isolated from well-differentiated HBE (WD-HBE)
cells by using a modified calcium shock method (Hastie et al., 1986;
Reed et al., 2000; Zhang et al., 2002). To remove membranes, Triton
X-100 was added to a final concentration of 0.5%, and samples were
incubated on ice for 15–25 min. Cilia were repelleted and the su-
pernatant/membrane fraction was removed. For select experiments,
axonemes were resuspended in 1.0% Triton X-100 and incubated on
ice for 25 min. All samples were immediately used or frozen on dry
ice and stored at 80°C until needed.
Preparations of freshly isolated axonemes were phosphorylated
in buffer containing 20 mM HEPES, pH 7.0, 1 mM MgCl2, 10 M
3-Isobutyl-1-methylxanthine (Sigma-Aldrich, St. Louis, MO), and a
1 dilution of phosphatase inhibitor cocktail 1 (P2850; Sigma-
Aldrich). Axonemes were incubated under five different reaction
conditions: 1) -32P–labeled ATP (1 Ci, 10 mCi/ml Easytides;
PerkinElmer Life Sciences, Boston, MA) alone; 2) ATP  10 M
cAMP (Sigma-Aldrich); 3) ATP, cAMP  10 M heat stable inhibitor
of protein kinase A (PKI) (6-22) amide (BIOMIOL Research Labo-
ratories, Plymouth Meeting, PA); 4) ATP  exogenous PKA cata-
lytic subunit (Promega, Madison, WI); and 5) ATP, exogenous PKA
catalytic subunit  PKI (6-22) amide. Reactions were incubated at
30°C for 30 min. Laemmeli loading dye was added to a final con-
centration of 1, and samples were resolved by SDS-PAGE. Gels
were dried and imaged using a STORM-840 PhosphorImager (Mo-
lecular Dynamics, Sunnyvale, CA).
Radiolabeled RII Overlays
Axonemal proteins (30 g/lane) were resolved on 15% SDS-PAGE
gels, transferred to nitrocellulose, and renatured in block (5% nonfat
dry milk, 0.1% bovine serum albumin in 1 Tris-buffered saline
[TBS: 50 mM Tris, 75 mM NaCl, pH 7.5] overnight at 4°C). Recom-
binant murine RII was phosphorylated by PKA catalytic subunit in
the presence of -32P–labeled ATP and unincorporated label was
removed using a desalting column. Renatured blots were incubated
with 250,000 cpm of 32P-RII/ml in block for 4 h at room tempera-
ture, washed in 1 TBS (5  15 min), and exposed to a Phospho-
rImager screen overnight. For competitive peptide experiments,
32P-RII was preincubated with either 1 M competitive peptide
Ht31 (DLIEEAASRIVDAVIEQVKAAGAY), 1 M negative control
peptide Ht31PP (DLIEEAASRPVDAVPEQVKAAGAY), or with no
peptide for 30 min before adding probe to the renatured blot. Both
Ht31 and Ht31PP were synthesized by the University of North
Carolina Custom Peptide Synthesis Facility.
Cloning of Novel AKAP
We screened a ZAP cDNA expression library (Stratagene, La Jolla,
CA) generated from mRNA isolated from WD-HBE cultures for
clones containing RII-binding proteins. Recombinant RII was puri-
fied from induced bacteria with cAMP agarose beads (Gray et al.,
1997). Purified RII was biotinylated using standard methods and
used as probe for nonradioactive library screens (Trotter et al., 1999).
XL1 Blue MRF’ Escherichia coli infected with ZAP phage were
plated and incubated at 42°C until plaques began to form, 4 h.
Nitrocellulose filters wet in 1 mM isopropyl -d-1-thiogalactopyr-
anoside were laid on plates and incubated for 5 h at 37°C for protein
collection. Filters were removed from plates, blocked in 5% nonfat
dry milk, probed overnight with RII-biotin prebound to streptavi-
din-alkaline phosphatase, and developed using standard methods.
Positive plaques were cored, tumbled, and rescreened. At least three
rounds of plaque purification were performed to isolate pure phage
encoding RII-binding domains. Positive clones were excised from
phage by in vivo excision, and inserts were sequenced by the
University of North Carolina Sequencing Facility. One novel 0.3-kb
cDNA sequence was isolated from the library screen. To obtain
full-length sequence we performed both 5 and 3 rapid amplifica-
tion of cDNA ends (RACE) using SMART-RACE (CLONTECH,
Palo Alto, CA) human trachea cDNA generated from RNA accord-
ing to the manufacturer’s protocol. RACE products were cloned into
pTAdv (CLONTECH) and sequenced. Appropriate primers were
designed and used to amplify full-length cDNAs of three predicted
splice variants from trachea and testis. Polymerase chain reaction
(PCR) products were again cloned into pTAdv and sequenced.
Identification of RII-binding Site
cDNAs encoding full-length (aa 1–197) and fragments (1–68 and
64–197) of AKAP28 were generated by PCR with the full-length
cDNA of AKAP28 as template. PCR products were subcloned into
the pET28c expression vector (Novagen, Madison, WI). After con-
firming the sequence of each insert, plasmids were transformed into
E. coli BL21 Codon Plus (Stratagene, La Jolla, CA) and expressed as
His6 fusion proteins. Fusion protein expression was induced over-
night at 28°C, and the insoluble fusion proteins were purified ac-
cording to the Novagen protein purification protocol. After purifi-
cation, fusion proteins were dialyzed into phosphate-buffered saline
(PBS) and subsequently resolubilized by boiling in 1% SDS in PBS.
Protein concentration was determined by a bicinchoninic acid pro-
tein assay (Pierce Chemical, Rockford, IL). Equal moles of each
fusion protein were resolved by SDS-PAGE, transferred to polyvi-
nylidene difluoride (PVDF), overlaid with biotinylated RII, probed
with stretavidin-conjugated horseradish peroxidase (HRP), and vi-
sualized using enhanced chemiluminescence (ECL) detection.
The predicted RII-binding site was mutated in the pET28c con-
struct encoding amino acids 1–68. Amino acid substitutions were
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made using the QuikChange XL site-directed mutagenesis kit (Strat-
agene). After sequence confirmation of the mutagenesis, the plas-
mid was expressed in bacteria as described above. The soluble
mutant fusion protein was purified on a nickel column according to
the manufacturer’s instructions (Novagen).
Heterologous Expression of AKAP28 and
Coimmunoprecipatation with PKA Subunits
Recombinant adenovirus encoding AKAP28 was generated for het-
erologous expression assays. A cDNA encoding AKAP28 fused to
the hemagglutinin (HA) epitope was subcloned into the adenovirus
shuttle vector pAdTrack-CMV (pAdTrack-CMV.HAAKAP28). Ac-
cording to the protocol of He et al. (1998), the Vector Core Facility at
University of North Carolina at Chapel Hill generated recombinant
adenoviruses, AdTrack-CMV (expressing green fluorescent protein
[GFP], from pAdTrack-CMV alone) and AdTrack-CMV-
HAAKAP28 (expressing GFP and AKAP28-epitope tagged with HA
at its carboxy terminus, from pAdTrack-CMV.HAAKAP28).
For heterologous expression, 100-mm dishes of 80% confluent
HeLa cells were either mock infected or infected with AdTrack-
CMV or AdTrack-CMV-HA-AKAP28. After a 2-h incubation at
37°C, cells were washed and the growth media were replaced.
Infected cells were harvested 24 h postinfection.
For immunoprecipation experiments, dishes of infected or mock-
infected cells were placed on ice and rinsed two times with ice-cold
PBS (50 mM NaH2PO4H2O, 150 mM NaCl, pH 7.4). Cells were
overlaid with 0.4 ml of ice-cold lysis buffer (20 mM HEPES, pH 7.4,
150 mM NaCl, 1% Triton X-100, 1% IGEPAL, plus protease inhibi-
tors) and removed by scraping. Lysates were passed through a
27-gauge needle several times and left on ice for 30 min. The
resulting homogenate was centrifuged at 14,300 relative centrifugal
force (rcf) for 10 min at 4°C to precipitate insoluble material. Protein
(300 g) was diluted to 0.5 ml in dilution buffer (lysis buffer without
IGEPAL) and incubated with 5 g of HA 1.1 monoclonal antibody
(Covance, Denver, PA) or isotype-matched IgG (R & D Systems,
Minneapolis, MN) while tumbling overnight at 4°C. Immunocom-
plexes were collected on protein G-agarose and washed extensively
with dilution buffer. Bound proteins were analyzed by Western
blotting with the appropriate antisera or by RII overlay.
Northern Blot Analysis of AKAP28
Total RNA from differentiating, code-matched human airway cul-
tures was isolated using the RNeasy mini kit (QIAGEN, Valencia,
CA) following the manufacturer’s instructions. RNA samples were
resolved on a 1.5% formaldehyde/agarose gel following standard
methods. After electrophoresis, samples were transferred to a Nyt-
ran membrane (Schleicher & Schuell, Keene, NH) by capillary blot-
ting and cross-linked using a Stratalinker (Stratagene). Both the time
course blot and a multiple tissue expression array (CLONTECH)
were probed with 32P-labeled random-primed cDNA corresponding
to nucleotides 98–400 of AKAP28 by using standard methods. All
blots were analyzed using a STORM-840 PhosphorImager and Im-
ageQuant software.
Antisera Generation and Immunoblot Analysis
Rabbit antisera directed against a GST fusion protein containing
amino acids 5–105 of AKAP28 were generated by Covance. Antisera
were affinity purified on a column containing His6AKAP28 fusion
protein and subsequently used for both Western blotting and im-
munohistochemistry. Preimmune sera were purified on an affi-gel
blue column (Pierce Chemical) to remove complement proteins.
For Western blots, proteins from isolated axonemes or WD-HBE
whole cell lysates were resolved by SDS-PAGE and transferred to
PVDF membranes. Membranes were blocked for at least 1 h in 10%
nonfat dry milk and incubated in 1 g/ml affinity-purified rabbit
anti-AKAP28 IgG, 1 g/ml preimmune IgG, 0.2 ng/ml affi-gel blue
purified anti-EBP50/NHERF IgG, or commercially available anti-
bodies specific for PKA catalytic subunit (0.1 g/ml; Santa Cruz
Biotechnology, Santa Cruz, CA), 0.1 g/ml PKA type I regulatory
subunit (Santa Cruz Biotechnology), 0.1 g/ml PKA type II regu-
latory subunit (Santa Cruz Biotechnology), or 1:2000 type IV 
tubulin (BioGenex, San Ramon, CA). Blots were incubated over-
night at 4°C or at room temperature for 1 h. Blots were washed,
incubated with appropriate HRP-conjugated secondary antibodies
(Jackson Immunoresearch, West Grove, PA), and visualized using
ECL.
Immunohistochemistry
Histological sections were prepared from paraffin-embedded, 4%
paraformaldehyde-fixed blocks of WD-HBE cells. For the analysis of
AKAP28 protein, sections were deparaffinzed and rehydrated to
water. Sections were rinsed with TBS and then incubated for 30 min
at 85°C in preheated, diluted (1.5 ml of concentrated stock in 160 ml
of water) antigen unmasking solution (Vector Laboratories, Burlin-
game, CA). Sections were washed in TBS and permeabilized in TBS
with 0.3% Triton X-100 for 30 min. Sections were blocked in 2%
normal goat serum, 1% cold water fish gelatin in TBS with 0.3%
Triton X-100 for 30 min. Primary antibodies diluted in block (5
g/ml) were incubated with sections overnight at 4°C. Slides were
washed in TBS and processed using the Vectashield Elite ABC kit
(Vector Laboratories). After final washes, sections were developed
using 3,3-diaminobenzidine tetrahydrochloride, counterstained
with light green SF yellowish (Chroma-Gesellschaft, Schmid Gmb;
Köngen, Germany), dehydrated, and mounted.
RESULTS
PKA Copurifies with Human Ciliary Axonemes and
Phosphorylates a 23-kDa Substrate
To determine whether PKA is associated with human ciliary
axonemes, we used both kinase activity assays and Western
blotting techniques. We isolated axonemes from WD-HBE
cells by using a modification of the calcium shock method
(Hastie et al., 1986; Reed et al., 2000; Zhang et al., 2002). As
shown by the electron micrograph (Figure 1A), the 9  2
microtubule structure characteristic of the axoneme is pre-
served during isolation and most axonemes are free of mem-
branes. To determine whether PKA was present in our ax-
onemal preparations, we treated isolated axonemes with
[-32P]ATP alone or [-32P]ATP plus 10 M cAMP, to spe-
cifically activate PKA (Figure 1B). Phosphatase inhibitors
were added to each reaction to inhibit known serine/threo-
nine phosphatases and L-isozymes of alkaline phosphatase.
A protein with an apparent molecular mass of 23 kDa is
specifically phosphorylated in the presence of 10 M cAMP
(lane 2), but is not detected under basal conditions (ATP
alone, lane 1). The phosphorylation of the 23-kDa band is
significantly reduced by the addition of PKI, a PKA-specific
inhibitor (lane 3) (Scott et al., 1986). Interestingly, the addi-
tion of exogenous PKA catalytic subunit results in the phos-
phorylation of many axonemal proteins, whereas endoge-
nous PKA specifically phosphorylates the 23-kDa protein
(compare lanes 2 and 4).
To determine the isoform(s) of PKA present in the axon-
eme, we used Western blotting techniques to detect specific
PKA subunits in isolated human axonemes (Figure 1C).
Axonemal preparations (5 g, lane 1) were compared with
whole cell lysates from WD-HBE cultures (5 g, lane 2). As
controls to confirm the purity of the axonemes, antibodies
for type IV  tubulin (-tubIV), the axonemal specific iso-
P.L. Kultgen et al.
Molecular Biology of the Cell4158
form of  tubulin (Renthal et al., 1993), and EBP50/NHERF,
a nonaxonemal, cytosolic protein (Short et al., 1998; Mohler
et al., 1999), were also used. As expected, type IV  tubulin
is highly enriched in the axonemal fraction and EBP50/
NHERF is not detectable in isolated axonemes, but is present
in whole cell lysates. The catalytic subunit of PKA (C), as
well as both type II (RII) and type I (RI) subunits, are
detectable by Western blot in ciliary axonemes.
To demonstrate that the signal for PKA was due to the
presence of the axonemes and not residual ciliary mem-
branes, we extracted our axonemal preparation with either
0.5 or 1.0% Triton X-100 (Figure 1D). Pelleted fractions
(AXO), presumably completely demembranated axonemes,
and detergent-extracted membranes (MEM) were compared
by Western blot with the PKA catalytic subunit antibody.
The catalytic subunit remains tightly associated with the
axoneme pellet in the presence of detergent and is not de-
tectable in the membrane fraction. Because the regulatory
subunits of PKA are generally thought to target the holoen-
zyme, it is likely that all PKA subunits remain with deter-
gent-extracted axonemes.
These experiments demonstrate that PKA copurifies with
demembranated human ciliary axonemes and preferentially
phosphorylates a single substrate. Therefore, PKA is associ-
ated with the axoneme as either a structural component or as
a constituent that strongly adheres to the axoneme through
the purification process. Additionally, PKA is likely an-
chored in proximity to its preferred 23-kDa substrate.
An Axonemal RII-Binding Protein Is Detectable by
Overlay
To determine how PKA is anchored within the axoneme, we
assessed whether PKA-binding proteins were also contained
within axonemes. In particular, we assayed for RII-binding
proteins by performing overlays with recombinant RII as
probe (Hausken et al., 1998). In radiolabeled RII overlay
assays of isolated cilia from WD-HBE cells, we repeatedly
detect two prominent RII-binding proteins (Figure 2A).
Competitive inhibitor peptide Ht31, but not Ht31PP, a neg-
ative control peptide, specifically blocked RII-binding to
these proteins. One of the detected proteins has an apparent
molecular mass of 50 kDa. This protein may be RII dimer-
izing with itself because RII is detectable at this molecular
mass by Western blot of cilia preparations (Figure 1C). The
other detected RII-binding protein is 28 kDa.
As seen with PKA (Figure 1D), the RII-binding protein
adheres tightly to the axoneme and is not extractable with
detergent (Figure 2B). In RII overlays comparing poorly
differentiated human airway cells lacking cilia with WD-
HBE cells, we find that the 28-kDa RII-binding protein is not
detectable in undifferentiated cells (Figure 2C) but is easily
detected in differentiated cells. At longer exposures, other
RII-binding proteins are faintly detected in whole cell lysates
(our unpublished data); however, the predominant proteins
detected by RII overlay in WD-HBE cells are 50 and 28 kDa.
Additionally, the putative AKAP is significantly enriched in
the axonemal fraction of the cell compared with whole cell
lysate (Figure 2D). These data suggest that the putative
AKAP specifically targets the axoneme. Because no AKAPs
of 28 kDa have been previously characterized, we designed
experiments to determine the molecular identity of this pro-
tein.
Determination of Axonemal AKAP Identity
To determine the identity of the axonemal AKAP, we
screened a cDNA expression library generated from mRNA
Figure 1. Detection of PKA in hu-
man airway cilia. (A) Representative
electronmicrograph of isolated hu-
man airway axonemes. (B) Freshly
isolated axonemes were incubated
under the following conditions: lane
1, [-32P]-ATP alone; lane 2, [-32P]-
ATP  10 M cAMP; lane 3, [-32P]-
ATP  10 M cAMP  10 M PKI;
lane 4, [-32P]-ATP  catalytic sub-
unit of PKA; and lane 5, [-32P]-ATP
 catalytic subunit of PKA  10 M
PKI. Treated samples were resolved
by SDS-PAGE and phosphorim-
aged. (C) Isolated axonemes (5 g,
lane 1) and WD-HBE cell lysates (5
g, lane 2 or 40 g, lane 3) were
resolved by 10% SDS-PAGE and
transferred to a PVDF membrane.
Membranes were probed with anti-
bodies specific for either the catalytic
subunit of PKA (C); the type II reg-
ulatory subunit of PKA (RII); the
type I regulatory subunit of PKA (RI); -tubulin type IV, the axonemal specific isoform of -tubulin; or EBP50/NHERF, a nonaxonemal, cytosolic protein.
Membranes were washed and incubated with appropriate secondary antibodies conjugated to HRP. Westerns were developed by enhanced chemilu-
minescence. All data are representative of multiple independent experiments. (D) Isolated axonemes were incubated with either 0.5 or 1.0% Triton X-100
for 25 min on ice. Detergent extracted axonemes (AXO) and membrane fractions (MEM) were resolved by SDS-PAGE, transferred to Immobilon and
probed with an antibody specific for the catalytic subunit of PKA. The membrane fraction is two-thirds the amount of axoneme fraction loaded.
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isolated from WD-HBE cultures by using recombinant, bio-
tinylated RII as probe. Three known AKAPs were identified
in our screen: AKAP350, a multiply spliced AKAP targeted
to the centrosome or Golgi complex of cells (Schmidt et al.,
1999; Takahashi et al., 1999); S-AKAP84, which colocalizes
with mitochondria in sperm flagella (Lin et al., 1995); and
AKAP220, an AKAP that is targeted to testicular peroxi-
somes (Lester et al., 1996). We also isolated one novel se-
quence from the library based on its ability to bind RII.
Sequence analysis revealed the insert contained 0.3 kb of a
novel cDNA with homology to a rat cDNA encoding
TAKAP80, a sperm fibrous sheath protein (Mei et al., 1997).
5 and 3 RACE and analyses of available expressed se-
quence tag and genomic databases were used to identify the
full-length sequence for the novel AKAP. This gene, which
maps to a region of chromosome Xq24 when searched
against the human genome database, seems to encode at
least three splice variants (submitted to National Center for
Biotechnology Information as AF514780, AF514781, and
AF514782). Full-length transcripts of all three splice variants
are present in both trachea and testis as determined by
reverse transcription (RT)-PCR. The full-length cDNA we
chose to characterize further (accession no. AF514780) en-
codes a protein of 197 amino acids that migrates at 28 kDa by
SDS-PAGE (see below). Following the tradition of the AKAP
community, we have named this protein AKAP28 for AKAP
of 28 kDa.
The novel clone found in the screening of the well-differ-
entiated airway cell cDNA expression library has no obvious
sequence homology with any previously characterized hu-
man proteins. The protein encoded by the open reading
frame of the AKAP cDNA does, however, share 50% identity
and 67% conserved homology to a 159-amino acid segment
of TAKAP80 (amino acids 340–499), a rat testis-specific,
developmentally regulated AKAP present on the fibrous
sheath of sperm (Figure 3) (Mei et al., 1997). The predicted
RII-binding region of TAKAP80 is contained in the 159-
amino acid stretch that shares significant homology to
AKAP28.
AKAP28 Contains a Single RII-binding Site
To map the location of the RII-binding site of AKAP28, we
performed RII overlay assays on purified, recombinant His6
fusion proteins containing amino acids 1–197 (FL), amino
acids 1–68 (NT), and amino acids 64–197 (CT) of AKAP28
(Figure 4A). Both FL and NT fusion proteins bind to biotin-
ylated RII by overlay, whereas the CT fusion protein does
not (Figure 4B). Moreover, preincubation of probe with the
competitive peptide HT31 blocks RII binding to His6-FL and
NT proteins, whereas the negative control peptide HT31PP
does not. Hence, RII binding to AKAP28 is specific and the
binding motif is contained within the first 68 amino acids of
AKAP28.
In all but one previously characterized AKAP (Diviani et
al., 2000), the RII-binding motif is an amphipathic helix that
binds to the RII subunit dimer. An amphipathic helix is
predicted to form between amino acids 35 and 52 of AKAP28.
On further analysis, we found that amino acids 35–52 can be
aligned with other AKAP RII-binding motifs and shares all of
the eight semiconserved positions predicted by Vijayaragha-
van et al. (1999). The binding motif is defined by:
X{L,I,V}X3{A,S}X2{L,I,V}{L,I,V}X2{L,I,V}{L,I,V}X2{A,S}{L,I,V},
where X is any amino acid and single letters in brackets rep-
resent the conserved amino acids that are favored at a partic-
ular position.
To provide experimental evidence that amino acids 35–52
define the RII-binding motif of AKAP28 we mutated resi-
dues 43L and 47V of the His6-NT fusion protein to prolines
(His6-P). The double mutant is similar to the substitutions
made in AKAP-Lbc to completely abolish RII-binding (Di-
viani et al., 2001). We predicted that these mutations would
disrupt the amphipathic helix and abolish RII binding in
AKAP28. The mutated protein runs aberrantly large by SDS-
PAGE and is unable to bind to RII as His6-NT does (Figure
4B). These data provide evidence that AKAP28 is an AKAP
Figure 2. Detection of RII-binding proteins in airway axonemes.
(A) Isolated axonemes (30 g/lane) were resolved by 15% SDS-
PAGE, transferred to nitrocellulose, and blocked overnight in 5%
nonfat dry milk, 0.1% bovine serum albumin in 1 TBS. Membranes
were incubated with 32P-labeled RII probe either preblocked with
no peptide, 1 M competitive Ht31, or 1 M negative control
Ht31PP. (B) Isolated axonemes were incubated with either 0.5 or
1.0% Triton X-100 for 25 min on ice. Detergent-extracted axonemes
(AXO) and membrane fractions (MEM) were resolved by SDS-
PAGE, transferred to PVDF, blocked, and incubated with 32P-la-
beled RII probe. The membrane fraction is two-thirds the amount of
axoneme fraction loaded. (C) Equal protein from whole cell lysates
of undifferentiated (UNDIF) and well-differentiated (DIF) human
primary airway cells were overlaid with radiolabeled RII. (D) Equal
protein from isolated axonemes and differentiated airway cell ly-
sates were also overlaid with radiolabeled RII. All data are repre-
sentative of multiple independent experiments.
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that contains a single RII-binding region located between
residues 35–52.
AKAP28 Associates with PKA in HeLa Cells
To determine whether AKAP28 associates with PKA in hu-
man cells as well as binding to RII by overlay, we expressed
HA-tagged AKAP28 in HeLa cells by using recombinant
adenovirus. Infected cells were lysed and coimmunoprepi-
tation experiments were performed with either HA antisera
or control IgG. Immune complexes from mock-infected
(mock), control-infected (expressing GFP), and infected (ex-
pressing GFP and HA-AKAP28) cells were either overlaid
with 32P-RII to detect AKAP28 or blotted to detect the pres-
ence of PKA subunits (C, RI, and RII) (Figure 4C). PKA
subunits were not detectable by Western in control IgG
precipitants (Figure 4C, lanes 2, 4, and 6) or from mock and
control-infected lysates treated with HA antisera (Figure 4C,
lanes 1 and 5). In contrast, both RII and C subunits of PKA
associate with HA-AKAP28 as determined by Western blot
(Figure 4C, lane 3). RI, however, does not seem to bind
HA-AKAP28 under these conditions (Figure 4C, lane 3).
AKAP28 preferentially binds type II PKA when heterolo-
gously expressed in a human cervical adenocarcinoma cell
line and is able to copurify with PKA catalytic subunit. This
suggests that AKAP28 functions as a type II PKA anchor
within cells.
Northern Blot Analysis of AKAP28
The mRNA expression of axonemal proteins is often up-
regulated as ciliated cells differentiate (Andrews et al., 1996;
Reed et al., 2000; Zhang et al., 2002). To determine whether
AKAP28 mRNA expression also follows this profile, we
examined the temporal expression of AKAP28 in differenti-
ating HBE cells. Initially, after plating the HBE cells are a
monolayer of undifferentiated cells (Figure 5A). Over time,
the cultures differentiate into a pseudostratified epithelium
similar to native tissue. Total RNA isolated from differenti-
ating HBE cells at 3, 10, 15, and 30 d postplating was ana-
lyzed by Northern blot with 32P-labeled, random primed
AKAP28 cDNA (nucleotides 98–400) as probe (Figure 5B).
Message for AKAP28 is not readily detected at early stages
of differentiation. However, AKAP28 gene expression
(0.8-kb message) is up-regulated as cells differentiate and
begin to display a mucociliary phenotype (days 10 and 15).
The absence of AKAP28 message in undifferentiated cells
and its up-regulation during differentiation suggest a func-
tional role for AKAP28 in differentiated HBE cells and is
consistent with the expression pattern observed for axon-
emal proteins.
We also probed a human multiple tissue array to deter-
mine the tissue distribution of AKAP28 (Figure 5C). We
found that AKAP28 is predominantly expressed in trachea
and testis; faint message was also detected in whole adult
and fetal lung. No other tissues were positive for the mes-
sage. Trachea, which contains ciliated columnar cells, and
testis, with both developing sperm and ciliated cells of the
ductuli efferentes of the epididymis, are the only tissues on
the blot that contain axoneme-based organelles. The tightly
restricted pattern of AKAP28 expression suggests that this
AKAP has a function specific for cells containing axonemes.
Localization and Distribution of AKAP28
To determine the subcellular distribution of AKAP28, we
generated rabbit polyclonal antisera directed against a GST
fusion protein containing amino acids 5–105. Antisera were
affinity purified and subsequently used for Western blotting
and tissue staining.
Proteins from isolated axonemes were analyzed with the
AKAP28 antisera. Parallel lanes of a single gel transferred to
PVDF membrane were either overlaid with RII or blotted
with AKAP28 antisera. As seen in Figure 6A, the 28-kDa
protein detected by RII overlay and AKAP28 as detected by
Western comigrate by SDS-PAGE. An equal amount of pu-
rified preimmune IgG does not detect a 28-kDa protein.
Thus, it is highly likely that the protein detected by RII
overlay is AKAP28. Additionally, as with the RII overlay
(Figure 2B) detergent extraction of the ciliary preparation
did not remove AKAP28 from the axoneme (Figure 6B).
We used immunohistochemistry to determine the distri-
bution of AKAP28 in WD-HBE cells (Figure 6C). Intense
staining for AKAP28 is seen in the cilia of columnar cells, but
absent from goblet and basal cells. Thus, AKAP28 localizes
Figure 3. Alignment of AKAP28 with TAKAP-80.
The amino acid sequences of AKAP28 and
TAKAP-80 were aligned by Clustal W. Identical res-
idues are shaded in black, whereas similar charged
residues are shaded gray. The predicted RII binding
site is marked with a dotted line.
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to airway cilia where it likely plays a role in anchoring PKA
near its axonemal substrate.
DISCUSSION
Several pharmacological studies have identified signaling
pathways involved in the regulation of ciliary beat fre-
quency. To better understand human deficiencies in muco-
ciliary clearance, it is necessary to delineate the molecular
mechanisms underlying these pathways. Specifically, we are
interested in understanding the molecular events linking the
production of cAMP, the subsequent activation of PKA, and
the associated increase in CBF. Our study provides the first
biochemical data showing that a pool of PKA is localized
within human ciliary axonemes (Figure 1). Under conditions
that should inhibit known serine/threonine phosphatases
and L-isozymes of alkaline phosphatase, this pool of enzyme
is responsible for the specific cAMP-dependent phosphory-
lation of a 23-kDa substrate (Figure 1B). Additionally, com-
partmentalization of type II PKA in the axoneme is likely
mediated via AKAP28, a novel axoneme-specific–anchoring
protein.
Changes in ciliary beat frequency are likely mediated via
a cascade of phosphorylation/dephosphorylation events
that alter the activity of axonemal proteins. In our studies of
isolated human ciliary axonemes, we have identified one
major 23-kDa protein that is phosphorylated in a cAMP-
dependent manner (Figure 1B). Parallels may be drawn to
other axonemal systems. For example, Salathe et al. (1993)
studied the in vitro cAMP-dependent phosphorylation of
ovine axonemes and found that a protein with an apparent
molecular mass of 26 kDa was consistently phosphorylated
(Salathe et al., 1993). Similar results were obtained in studies
of Paramecium (29-kDa), mussel gill (27-kDa), and Tetrahy-
mena (34-kDa) axonemes (Stommel and Stephens, 1985; Ha-
masaki et al., 1989; Chilcote and Johnson, 1990).
Further studies in Paramecium revealed that p29, the ax-
onemal protein consistently phosphorylated in this species,
copurified with the 22S outer arm dynein (Bonini and Nel-
son, 1990; Hamasaki et al., 1991). Additionally, cAMP-de-
pendent phosphorylation of p29 has been linked to both
increased swimming velocity of permeabilized paramecia
and increased velocity of microtubules gliding across sur-
faces coated with dynein isolated from phosphorylated ax-
onemes (Barkalow et al., 1994). In studies of Tetrahymena, it
has been demonstrated that its PKA substrate, p34 also
copurifies with 22S dynein (Christensen et al., 2001). In a
number of biochemical tests, Christensen et al. (2001) ele-
gantly demonstrate that p34 is the functional ortholog of the
Paramecium 22S regulatory light chain p29. Functionally it
seems the regulation of ciliary motility by PKA involves the
phosphorylation of a dynein regulatory light chain. To date,
however, the primary sequence of this regulatory light chain
has not been determined.
Both type I and type II isoforms of PKA are detectable by
Western blot in human ciliary axonemes (Figure 1C). Al-
though the kinetic and enzymatic specificities of the three
catalytic subunits (C, , and ) of PKA are indistinguish-
able, different regulatory subunits (RI and RII) display dif-
ferent cAMP-binding affinities and are differentially located
within the cell. RI ( and ) is mainly cytoplasmic; however,
at times it is compartmentalized. For example, RI holoen-
zyme is tightly bound to plasma membranes of erythrocytes
and is enriched at the neuromuscular junction (Rubin et al.,
1972; Imaizumi-Scherrer et al., 1996). Additionally, RI is
associated with activated B-cell receptors and accumulates
at the “cap” site when lymphocytes are stimulated with
anti-CD3 antibodies (Skalhegg et al., 1994; Levy et al., 1996).
In contrast, RII ( and ) often tightly associates with cellu-
lar structures and organelles. No studies determining the
specific roles of RI and RII within the axoneme have been
conducted. Electron microscopic studies of axonemes with
RI- and RII-specific antibodies will be necessary to deter-
mine where each PKA isotype is localized within this struc-
Figure 4. Analysis of PKA binding to AKAP28. (A) Schematic
representation of full-length and truncation His6-AKAP28 proteins.
All proteins are drawn to scale and the amino acid numbers are
shown. (B) Equal moles of His6 fusion proteins were resolved by
SDS-PAGE, transferred to PVDF membrane, probed with biotinyl-
ated RII, subsequently incubated with streptavidin-HRP, and de-
veloped with ECL. Biotinylated RII was either preblocked with no
peptide, 1 M competitive Ht31 or 1 M negative control Ht31PP.
A representative Ponceau-stained membrane is also shown. (C)
HeLa cells were either mock infected (MOCK) or infected with a
control adenovirus expressing GFP, or an adenovirus expressing
both GFP and HA-tagged AKAP28 (AKAP28). Cells lysates (300 g)
were incubated with monoclonal HA.11 or mouse IgG1a. Immuno-
complexes were collected on protein G and subsequently analyzed
by Western blot or RII overlay as indicated. Inputs (one-fifth of
total) for all cell lysates are shown. Lanes 1, 3, and 5 were incubated
with HA antisera, whereas 2, 4, and 6 were incubated with mouse
IgG1a. All data are representative of multiple independent experi-
ments.
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ture. Moreover, we are uncertain whether type I PKA and
type II PKA serve overlapping or distinct roles in the axon-
eme. Pharmacological experiments using isotype-specific
agonists will be necessary to delineate the roles of RI and RII
in the regulation of CBF.
In this study, we have focused on identifying the protein
responsible for anchoring type II PKA in the axoneme. We
have determined the molecular identity of AKAP28, an
AKAP highly enriched in airway cilia. Due to the insolubil-
ity of the axoneme, we are unable to coimmunoprecipate
AKAP28 with its binding partners from primary airway
cells. Using a heterologous system, however, we have been
able to coimmunoprecipate epitope-tagged AKAP28 with
both RII and PKA catalytic subunit from HeLa cells (Figure
4C). We are unable to detect RI in the same immune com-
plexes. This experimental evidence for preferential binding
to RII is in agreement with the RI/RII binding predictions
made by Miki and Eddy (1999) in Ala- and Val-scanning
mutagenesis studies of AKAP-binding domains. These data
show that AKAP28 preferentially binds type II PKA and
likely serves as its anchor in the axoneme.
Because type I PKA also copurifies with axonemes (Figure
1C), RI-specific–anchoring proteins are also likely to be
present. Unlike RII-binding proteins, RI-specific AKAPs are
not detectable by overlay (Miki and Eddy, 1999). Identifying
RI-binding AKAPs in the axoneme is difficult because the
insolubility of this organelle prohibits the coimmunoprecipi-
tation experiments necessary for the detection of RI-binding
proteins.
Sequence analysis indicates that AKAP28 is most closely
related to a rat testis-specific, developmentally regulated
AKAP, TAKAP-80 (Mei et al., 1997). A 159-amino acid
stretch (residues 340–499) at the carboxy terminus of
TAKAP-80 shares 50% identity and 67% conserved homol-
ogy with amino acids 33–192 of AKAP28 (Figure 3). In
contrast, no similarity is found in the N termini of these
proteins. According to Mei et al. (1997), TAKAP-80 is exclu-
sively expressed in testis where mRNA expression is up-
regulated during a time interval that corresponds to the
initiation of spermiogenesis (Mei et al., 1997). In the study by
Mei et al. (1997), total RNA from whole lung was probed,
however, no message was detected. Either TAKAP-80 is not
present in rat lung or the percentage of RNA from ciliated
cells was too low to detect TAKAP-80 mRNA expression on
the blot. Because tracheal RNA was not tested, we are un-
certain whether TAKAP-80 is specifically expressed in rat
testis or whether TAKAP-80 is the rat ortholog of human
AKAP28. TAKAP-80 protein was detected by Western blot
in fibrous sheath preparations from rat sperm, but no stain-
ing of rat tissues has been published. In contrast, our stain-
ing of airway sections with AKAP28-specific antibodies in-
dicates that AKAP28 is enriched in airway cilia. It is also
detectable by Western blot in axoneme preparations. We
have not determined the localization of AKAP28 in testis
and sperm. Because many components of ciliary and flagel-
lar axonemes are conserved, it is likely that a protein tar-
geted to ciliary axonemes would also localize to the axon-
eme of sperm flagella. Another possibility, however, is that
AKAP28 contains both fibrous sheath- and axoneme-target-
ing information. In ciliated airway cells, where fibrous
sheaths do not exist, the protein would be compartmental-
ized in the axoneme. In sperm, AKAP28 could preferentially
Figure 5. Northern blot analysis of AKAP28. (A)
Code-matched HBE cultures were differentiated on
semipermeable supports. Cultures were fixed post-
plating at day 3, 10, 15, and 30. Cells were sectioned
and stained with H&E. (B) Total RNA isolated from
differentiating HBE cells at 3, 10, 15, and 30 d post-
plating (20 g/lane for samples 3, 10, and 15; 6
g/lane for 30) was analyzed by Northern blot with
32P-random primed cDNA corresponding to nucle-
otides 98–400 of AKAP28 cDNA. The same blot was
probed with G3PDH as a loading control. Similar
results were obtained on two separate blots. (C) A
multiple tissue expression array was probed with
the same AKAP28 probe used in B. A selected panel
is shown; all tissues not shown were negative for
the signal.
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target the fibrous sheath. Further study of AKAP28 in both
sperm and testis is needed to resolve these questions.
In addition to AKAP28, we have identified two smaller
splice variants expressed from the same gene (National Cen-
ter for Biotechnology Information accession no. AF514781
and AF514782). The predicted splice variants were initially
detected by 5 and 3 RACE of human tracheal cDNA and by
the examination of expressed sequence tag databases. Their
presence was confirmed in both trachea and testis by RT-
PCR and the subsequent sequencing of amplified products.
All three splice variants of this gene are detected by RT-PCR
in both tissues. To date, we have not detected the predicted
AKAP28 isoforms by Western blot of axonemes or in whole
cell lysates of WD-HBE cells. Either the predicted splice
forms are never translated into protein or are expressed at
low levels that currently prohibit detection.
Axonemal AKAPs have also been detected in Chlamydo-
monas flagella. However, unlike RII overlays of human cili-
ary axonemes where RII-binding proteins of 50 and 28 kDa
are detected (Figure 2A), AKAPs of 240 and 97 kDa are
detected in Chlamydomonas flagellar axonemes (Gaillard et
al., 2001). Using genetic mutants of Chlamydomonas, Gaillard
et al. (2001) found that AKAP240 is a component of the
central pair apparatus and that AKAP97 is part of the radial
spoke stalk. The molecular identity of AKAP240 has not
been determined; however, AKAP97 has been defined mo-
lecularly as radial spoke protein 3 (RSP3). To date, the
human ortholog of RSP3 has not been characterized. Al-
though both human and Chlamydomonas axoneme systems
contain AKAPs, based on size, the AKAPs readily detected
in each system do not seem to be the same proteins. One
possibility is that human RSP3 may be a lower affinity
AKAP than AKAP28 or found at a lower concentration than
AKAP28 in human axonemal preparations. Also, this differ-
ence could be due to species variations or in differences
between flagella and cilia. In Chlamydomonas, agents that
reduce cAMP concentrations or inhibit the activity of PKA
increase axoneme motility (Hasegawa et al., 1987). The in-
hibitory effect of cAMP on Chlamydomonas axonemes is op-
posite of the stimulatory effect seen in other organisms.
Moreover, unlike the relatively small phosphoproteins de-
tected in other axoneme-based systems in response to
cAMP, two proteins of 270 kDa are phosphorylated in
response to cAMP in Chlamydomonas (Hasegawa et al., 1987).
Although many axonemal proteins are conserved across
species, specific signaling pathways and the compartmen-
talization of particular components vary.
In summary, we have presented the first biochemical data
demonstrating the copurification of PKA with human ciliary
axonemes. Additionally, we have identified the first human
A-kinase anchoring protein targeted to the axoneme. We pro-
pose that AKAP28 localizes PKA to a position in the axoneme
where it is able to readily interact with its substrate. This
compartmentalization likely plays a role in the regulation of
outer dynein arm activity and the control of ciliary beat fre-
quency. Future experiments will be designed to examine the
physiological role AKAP28 plays in human cilia.
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